Shambles
Bluelight Crew
**Previous incarnation >>HERE<<**
Came across this whilst pottering and thought it worth posting here...
Yes there is the usual handwringing selection of dead young women attractive and middle-class enough to be newsworthy - and the obligatory interview with a distraught mother or two - but the more HR-relevant stuff mentioned in the title is worth a read. I know there's been similar concerns about the way certain prescription and OTC drugs effect women quite differently to men (and quite differently again depending on what stage of the monthly cycle she happens to be on at the time). Seems the fudging of drug trials over... well over the history of drug trials really, that largely excludes women participants could turn out to be a fairly significant problem. And one that also applies to recreationals - especially amphetamine-family recreationals.
Came across this whilst pottering and thought it worth posting here...
How Your Menstrual Cycle Can Affect Your Reaction to MDMA
Deaths related to MDMA are at an all-time high. In September of 2015, a report from the Office of National Statistics showed that deaths had increased from eight in 2013 to 50 in 2014. In the last few years, Boomtown Festival has seen the deaths of both Deborah Jeffery and Lisa Williamson. In June of this year, 16-year-old Sky Nicol died after taking five times the fatal level of MDMA. The same month, 22-year-old Stephanie Shevlin died after taking MDMA at The Box nightclub in Crewe. Later the same month, 17-year-old Emily Lyon died after taking MDMA at Red Bull Culture Clash at the O2.
These tragic cases are just a few of many. But no one is highlighting a blinding fact: that a large proportion of the deaths have been young British women.
The results of the 2016 Global Drugs Survey revealed that there's been a fourfold increase in British female clubbers seeking emergency medical treatment in the last three years. In addition, women are two to three times more likely to seek that treatment than men. This isn't a coincidence, so what are the reasons for this significant split? Why are women so at risk?
(linky to rest of article)
Yes there is the usual handwringing selection of dead young women attractive and middle-class enough to be newsworthy - and the obligatory interview with a distraught mother or two - but the more HR-relevant stuff mentioned in the title is worth a read. I know there's been similar concerns about the way certain prescription and OTC drugs effect women quite differently to men (and quite differently again depending on what stage of the monthly cycle she happens to be on at the time). Seems the fudging of drug trials over... well over the history of drug trials really, that largely excludes women participants could turn out to be a fairly significant problem. And one that also applies to recreationals - especially amphetamine-family recreationals.
Last edited: